CD34 and central nervous system cancer: Although a few of pediatric gliomas share these molecular features with GG (Blümcke et al., 1999; Reifenberger et al., 2003; Giulioni et al., 2019), CD34 expression and BRAFV600E mutation, as an adjunct diagnostic marker, are routinely screened for the diagnosis of GG (Blümcke et al., 1999; Schindler et al., 2011; Xing et al., 2021).